Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2023 Earnings Call Transcript May 8, 2023
Axsome Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-1.04.
Operator: Hello and welcome to the Axsome Therapeutics First Quarter 2023 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to turn the call over to Mark Jacobson. Please go ahead, Mark.
Mark Jacobson: Thank you,...
